Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody

Fang Li; Meng Luo; Wenyang Zhou; Jinliang Li; Xiyun Jin; Zhaochun Xu; Liran Juan; Zheng Zhang; Yuou Li; Renqiang Liu; Yiqun Li; Chang Xu; Kexin Ma; Huimin Cao; Jingwei Wang; Pingping Wang; Zhigao Bu; Qinghua Jiang

doi:10.1007/s13238-020-00807-6

Protein Cell ›› 2021, Vol. 12 ›› Issue (10) : 751 -755. DOI: 10.1007/s13238-020-00807-6

HIGHLIGHT

Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody

Author information +

History +

PDF (1673KB)

Cite this article

Download citation ▾

Fang Li, Meng Luo, Wenyang Zhou, Jinliang Li, Xiyun Jin, Zhaochun Xu, Liran Juan, Zheng Zhang, Yuou Li, Renqiang Liu, Yiqun Li, Chang Xu, Kexin Ma, Huimin Cao, Jingwei Wang, Pingping Wang, Zhigao Bu, Qinghua Jiang. Single cell RNA and immune repertoire profiling of COVID-19 patients reveal novel neutralizing antibody. Protein Cell, 2021, 12(10): 751-755 DOI:10.1007/s13238-020-00807-6

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Cai J, Sun W, Huang J, Gamber M, Wu J, He G (2020) Indirect virus transmission in cluster of COVID-19 cases, Wenzhou, China, 2020. Emerg Infect Dis J 26(6):1343–1345

[2]	Cao Y, Su B, Guo X, Sun W, Deng Y, Bao L, Zhu Q, Zhang X, Zheng Y, Geng C (2020) Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients’ B cells. Cell 182:73-84.e16

[3]	Gitlin AD, von Boehmer L, Gazumyan A, Shulman Z, Oliveira TY, Nussenzweig MC (2016) Independent roles of switching and hypermutation in the development and persistence of B lymphocyte memory. Immunity 44:769–781

[4]	Hu X, Zhang J, Wang J, Fu J, Li T, Zheng X, Wang B, Gu S, Jiang P, Fan J (2019) Landscape of B cell immunity and related immune evasion in human cancers. Nat Genet 51:560–567

[5]	Lv Z, Deng Y-Q, Ye Q, Cao L, Sun C-Y, Fan C, Huang W, Sun S, Sun Y, Zhu L (2020) Structural basis for neutralization of SARSCoV-2 and SARS-CoV by a potent therapeutic antibody. Science 369:1505–1509

[6]	Palladino G, Mozdzanowska K, Washko G, Gerhard W (1995) Virusneutralizing antibodies of immunoglobulin G (IgG) but not of IgM or IgA isotypes can cure influenza virus pneumonia in SCID mice. J Virol 69:2075–2081

[7]	Thevarajan I, Nguyen THO, Koutsakos M, Druce J, Caly L, van de Sandt CE, Jia X, Nicholson S, Catton M, Cowie B (2020) Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19. Nat Med 26:453–455

[8]	Wang J, Shuai L, Wang C, Liu R, He X, Zhang X, Sun Z, Shan D, Ge J, Wang X(2020) Mouse-adapted SARS-CoV-2 replicates efficiently in the upper and lower respiratory tract of BALB/c and C57BL/6J mice. Protein Cell 11(10):1–7

[9]	Wu S, Zhong G, Zhang J, Shuai L, Zhang Z, Wen Z, Wang B, Zhao Z, Song X, Chen Y(2020) A single dose of an adenovirusvectored vaccine provides protection against SARS-CoV-2 challenge. Nat Commun 11:4081

[10]	Zou Q, Hu Q, Guo M, Wang G (2015) HAlign: fast multiple similar DNA/RNA sequence alignment based on the centre star strategy. Bioinformatics 31:2475–2481